Your browser doesn't support javascript.
loading
Identification and functional characterization of FMN2, a regulator of the cyclin-dependent kinase inhibitor p21.
Yamada, Kayo; Ono, Motoharu; Perkins, Neil D; Rocha, Sonia; Lamond, Angus I.
  • Yamada K; Centre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dundee, UK.
Mol Cell ; 49(5): 922-33, 2013 Mar 07.
Article en En | MEDLINE | ID: mdl-23375502
ABSTRACT
The ARF tumor suppressor is a central component of the cellular defense against oncogene activation in mammals. p14ARF activates p53 by binding and inhibiting HDM2, resulting, inter alia, in increased transcription and expression of the cyclin-dependent kinase inhibitor p21 and consequent cell-cycle arrest. We analyzed the effect of p14ARF induction on nucleolar protein dynamics using SILAC mass spectrometry and have identified the human Formin-2 (FMN2) protein as a component of the p14ARF tumor suppressor pathway. We show that FMN2 is increased upon p14ARF induction at both the mRNA and the protein level via a NF-κB-dependent mechanism that is independent of p53. FMN2 enhances expression of the cell-cycle inhibitor p21 by preventing its degradation. FMN2 is also induced by activation of other oncogenes, hypoxia, and DNA damage. These results identify FMN2 as a crucial component in the regulation of p21 and consequent oncogene/stress-induced cell-cycle arrest in human cells.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidor p21 de las Quinasas Dependientes de la Ciclina / Proteínas del Tejido Nervioso Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2013 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidor p21 de las Quinasas Dependientes de la Ciclina / Proteínas del Tejido Nervioso Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2013 Tipo del documento: Article